ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intramuscular HPV Vaccine Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-17F15371
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Intramuscular HPV Vaccine Market Research Report 2023
BUY CHAPTERS

Global Intramuscular HPV Vaccine Market Research Report 2025

Code: QYRE-Auto-17F15371
Report
June 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Sanofi
GSK
Serum Institute
Astellas Pharma
CSL Limited
Emergent Biosolutions
GlaxoSmithKline PLC
Johnson & Johnson
MedImmune
Walvax Biotechnology
Liaoning Chengda Biotechnology
Hualan Biological Engineering
SINOVAC BIOTECH
Chongqing Zhifei Biological Products
Merck Sharp & Dohme (MSD)
Chang Chun High and New Technology Industries (Group)
Beijing Wantai Biological Pharmacy Enterprise
Jiangsu Recbio Technology

Intramuscular HPV Vaccine Market

The global market for Intramuscular HPV Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The intramuscular HPV vaccine is a vaccine to prevent human papillomavirus infection. It boosts the body"s immunity against papillomaviruses by injecting the vaccine into muscle tissue, which triggers an immune response.
The characteristics and precautions of intramuscular injection of HPV vaccine include: recommended age, vaccine dose and vaccination schedule, vaccination site, safety and side effects, catch-up and vaccination recommendations.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intramuscular HPV Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intramuscular HPV Vaccine.
The Intramuscular HPV Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intramuscular HPV Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intramuscular HPV Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intramuscular HPV Vaccine Market Report

Report Metric Details
Report Name Intramuscular HPV Vaccine Market
Segment by Type
  • Bivalent
  • Quadrivalent
  • Nine-valent
Segment by Application
  • Male
  • Female
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck Sharp & Dohme (MSD), Pfizer, Sanofi, GSK, Serum Institute, Astellas Pharma, CSL, Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, MedImmune, Walvax Biotechnology, Liaoning Chengda Biotechnology, Hualan Biological Engineering, Sinovac Biotech, Chongqing Zhifei Biological Products, Chang Chun High and New Technology Industries (Group), Beijing Wantai Biological Pharmacy Enterprise, Jiangsu Recbio Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intramuscular HPV Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intramuscular HPV Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Intramuscular HPV Vaccine Market report?

Ans: The main players in the Intramuscular HPV Vaccine Market are Merck Sharp & Dohme (MSD), Pfizer, Sanofi, GSK, Serum Institute, Astellas Pharma, CSL, Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, MedImmune, Walvax Biotechnology, Liaoning Chengda Biotechnology, Hualan Biological Engineering, Sinovac Biotech, Chongqing Zhifei Biological Products, Chang Chun High and New Technology Industries (Group), Beijing Wantai Biological Pharmacy Enterprise, Jiangsu Recbio Technology

What are the Application segmentation covered in the Intramuscular HPV Vaccine Market report?

Ans: The Applications covered in the Intramuscular HPV Vaccine Market report are Male, Female

What are the Type segmentation covered in the Intramuscular HPV Vaccine Market report?

Ans: The Types covered in the Intramuscular HPV Vaccine Market report are Bivalent, Quadrivalent, Nine-valent

Recommended Reports

HPV and Cancer Testing

HPV Vaccines

Other Preventive Vaccines

1 Intramuscular HPV Vaccine Market Overview
1.1 Product Definition
1.2 Intramuscular HPV Vaccine by Type
1.2.1 Global Intramuscular HPV Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bivalent
1.2.3 Quadrivalent
1.2.4 Nine-valent
1.3 Intramuscular HPV Vaccine by Application
1.3.1 Global Intramuscular HPV Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Male
1.3.3 Female
1.4 Global Intramuscular HPV Vaccine Market Size Estimates and Forecasts
1.4.1 Global Intramuscular HPV Vaccine Revenue 2020-2031
1.4.2 Global Intramuscular HPV Vaccine Sales 2020-2031
1.4.3 Global Intramuscular HPV Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intramuscular HPV Vaccine Market Competition by Manufacturers
2.1 Global Intramuscular HPV Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intramuscular HPV Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intramuscular HPV Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intramuscular HPV Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intramuscular HPV Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intramuscular HPV Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Intramuscular HPV Vaccine, Date of Enter into This Industry
2.8 Global Intramuscular HPV Vaccine Market Competitive Situation and Trends
2.8.1 Global Intramuscular HPV Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intramuscular HPV Vaccine Players Market Share by Revenue
2.8.3 Global Intramuscular HPV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intramuscular HPV Vaccine Market Scenario by Region
3.1 Global Intramuscular HPV Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intramuscular HPV Vaccine Sales by Region: 2020-2031
3.2.1 Global Intramuscular HPV Vaccine Sales by Region: 2020-2025
3.2.2 Global Intramuscular HPV Vaccine Sales by Region: 2026-2031
3.3 Global Intramuscular HPV Vaccine Revenue by Region: 2020-2031
3.3.1 Global Intramuscular HPV Vaccine Revenue by Region: 2020-2025
3.3.2 Global Intramuscular HPV Vaccine Revenue by Region: 2026-2031
3.4 North America Intramuscular HPV Vaccine Market Facts & Figures by Country
3.4.1 North America Intramuscular HPV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intramuscular HPV Vaccine Sales by Country (2020-2031)
3.4.3 North America Intramuscular HPV Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intramuscular HPV Vaccine Market Facts & Figures by Country
3.5.1 Europe Intramuscular HPV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intramuscular HPV Vaccine Sales by Country (2020-2031)
3.5.3 Europe Intramuscular HPV Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intramuscular HPV Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Intramuscular HPV Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intramuscular HPV Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Intramuscular HPV Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intramuscular HPV Vaccine Market Facts & Figures by Country
3.7.1 Latin America Intramuscular HPV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intramuscular HPV Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Intramuscular HPV Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intramuscular HPV Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Intramuscular HPV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intramuscular HPV Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intramuscular HPV Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intramuscular HPV Vaccine Sales by Type (2020-2031)
4.1.1 Global Intramuscular HPV Vaccine Sales by Type (2020-2025)
4.1.2 Global Intramuscular HPV Vaccine Sales by Type (2026-2031)
4.1.3 Global Intramuscular HPV Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Intramuscular HPV Vaccine Revenue by Type (2020-2031)
4.2.1 Global Intramuscular HPV Vaccine Revenue by Type (2020-2025)
4.2.2 Global Intramuscular HPV Vaccine Revenue by Type (2026-2031)
4.2.3 Global Intramuscular HPV Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Intramuscular HPV Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intramuscular HPV Vaccine Sales by Application (2020-2031)
5.1.1 Global Intramuscular HPV Vaccine Sales by Application (2020-2025)
5.1.2 Global Intramuscular HPV Vaccine Sales by Application (2026-2031)
5.1.3 Global Intramuscular HPV Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Intramuscular HPV Vaccine Revenue by Application (2020-2031)
5.2.1 Global Intramuscular HPV Vaccine Revenue by Application (2020-2025)
5.2.2 Global Intramuscular HPV Vaccine Revenue by Application (2026-2031)
5.2.3 Global Intramuscular HPV Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Intramuscular HPV Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck Sharp & Dohme (MSD)
6.1.1 Merck Sharp & Dohme (MSD) Company Information
6.1.2 Merck Sharp & Dohme (MSD) Description and Business Overview
6.1.3 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product Portfolio
6.1.5 Merck Sharp & Dohme (MSD) Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Intramuscular HPV Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Intramuscular HPV Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 GSK
6.4.1 GSK Company Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GSK Intramuscular HPV Vaccine Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Company Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serum Institute Intramuscular HPV Vaccine Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Astellas Pharma
6.6.1 Astellas Pharma Company Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Astellas Pharma Intramuscular HPV Vaccine Product Portfolio
6.6.5 Astellas Pharma Recent Developments/Updates
6.7 CSL
6.7.1 CSL Company Information
6.7.2 CSL Description and Business Overview
6.7.3 CSL Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CSL Intramuscular HPV Vaccine Product Portfolio
6.7.5 CSL Recent Developments/Updates
6.8 Emergent BioSolutions
6.8.1 Emergent BioSolutions Company Information
6.8.2 Emergent BioSolutions Description and Business Overview
6.8.3 Emergent BioSolutions Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Emergent BioSolutions Intramuscular HPV Vaccine Product Portfolio
6.8.5 Emergent BioSolutions Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Company Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GlaxoSmithKline Intramuscular HPV Vaccine Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Company Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Johnson & Johnson Intramuscular HPV Vaccine Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 MedImmune
6.11.1 MedImmune Company Information
6.11.2 MedImmune Description and Business Overview
6.11.3 MedImmune Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 MedImmune Intramuscular HPV Vaccine Product Portfolio
6.11.5 MedImmune Recent Developments/Updates
6.12 Walvax Biotechnology
6.12.1 Walvax Biotechnology Company Information
6.12.2 Walvax Biotechnology Description and Business Overview
6.12.3 Walvax Biotechnology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Walvax Biotechnology Intramuscular HPV Vaccine Product Portfolio
6.12.5 Walvax Biotechnology Recent Developments/Updates
6.13 Liaoning Chengda Biotechnology
6.13.1 Liaoning Chengda Biotechnology Company Information
6.13.2 Liaoning Chengda Biotechnology Description and Business Overview
6.13.3 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product Portfolio
6.13.5 Liaoning Chengda Biotechnology Recent Developments/Updates
6.14 Hualan Biological Engineering
6.14.1 Hualan Biological Engineering Company Information
6.14.2 Hualan Biological Engineering Description and Business Overview
6.14.3 Hualan Biological Engineering Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hualan Biological Engineering Intramuscular HPV Vaccine Product Portfolio
6.14.5 Hualan Biological Engineering Recent Developments/Updates
6.15 Sinovac Biotech
6.15.1 Sinovac Biotech Company Information
6.15.2 Sinovac Biotech Description and Business Overview
6.15.3 Sinovac Biotech Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Sinovac Biotech Intramuscular HPV Vaccine Product Portfolio
6.15.5 Sinovac Biotech Recent Developments/Updates
6.16 Chongqing Zhifei Biological Products
6.16.1 Chongqing Zhifei Biological Products Company Information
6.16.2 Chongqing Zhifei Biological Products Description and Business Overview
6.16.3 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product Portfolio
6.16.5 Chongqing Zhifei Biological Products Recent Developments/Updates
6.17 Chang Chun High and New Technology Industries (Group)
6.17.1 Chang Chun High and New Technology Industries (Group) Company Information
6.17.2 Chang Chun High and New Technology Industries (Group) Description and Business Overview
6.17.3 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product Portfolio
6.17.5 Chang Chun High and New Technology Industries (Group) Recent Developments/Updates
6.18 Beijing Wantai Biological Pharmacy Enterprise
6.18.1 Beijing Wantai Biological Pharmacy Enterprise Company Information
6.18.2 Beijing Wantai Biological Pharmacy Enterprise Description and Business Overview
6.18.3 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product Portfolio
6.18.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
6.19 Jiangsu Recbio Technology
6.19.1 Jiangsu Recbio Technology Company Information
6.19.2 Jiangsu Recbio Technology Description and Business Overview
6.19.3 Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Jiangsu Recbio Technology Intramuscular HPV Vaccine Product Portfolio
6.19.5 Jiangsu Recbio Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intramuscular HPV Vaccine Industry Chain Analysis
7.2 Intramuscular HPV Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intramuscular HPV Vaccine Production Mode & Process Analysis
7.4 Intramuscular HPV Vaccine Sales and Marketing
7.4.1 Intramuscular HPV Vaccine Sales Channels
7.4.2 Intramuscular HPV Vaccine Distributors
7.5 Intramuscular HPV Vaccine Customer Analysis
8 Intramuscular HPV Vaccine Market Dynamics
8.1 Intramuscular HPV Vaccine Industry Trends
8.2 Intramuscular HPV Vaccine Market Drivers
8.3 Intramuscular HPV Vaccine Market Challenges
8.4 Intramuscular HPV Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Sanofi
GSK
Serum Institute
Astellas Pharma
CSL Limited
Emergent Biosolutions
GlaxoSmithKline PLC
Johnson & Johnson
MedImmune
Walvax Biotechnology
Liaoning Chengda Biotechnology
Hualan Biological Engineering
SINOVAC BIOTECH
Chongqing Zhifei Biological Products
Merck Sharp & Dohme (MSD)
Chang Chun High and New Technology Industries (Group)
Beijing Wantai Biological Pharmacy Enterprise
Jiangsu Recbio Technology
List of Tables
 Table 1. Global Intramuscular HPV Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intramuscular HPV Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intramuscular HPV Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intramuscular HPV Vaccine Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intramuscular HPV Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intramuscular HPV Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intramuscular HPV Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intramuscular HPV Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intramuscular HPV Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intramuscular HPV Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intramuscular HPV Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Intramuscular HPV Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intramuscular HPV Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular HPV Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intramuscular HPV Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intramuscular HPV Vaccine Sales by Region (2020-2025) & (Units)
 Table 18. Global Intramuscular HPV Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Intramuscular HPV Vaccine Sales by Region (2026-2031) & (Units)
 Table 20. Global Intramuscular HPV Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Intramuscular HPV Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intramuscular HPV Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Intramuscular HPV Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intramuscular HPV Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Intramuscular HPV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intramuscular HPV Vaccine Sales by Country (2020-2025) & (Units)
 Table 27. North America Intramuscular HPV Vaccine Sales by Country (2026-2031) & (Units)
 Table 28. North America Intramuscular HPV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intramuscular HPV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intramuscular HPV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intramuscular HPV Vaccine Sales by Country (2020-2025) & (Units)
 Table 32. Europe Intramuscular HPV Vaccine Sales by Country (2026-2031) & (Units)
 Table 33. Europe Intramuscular HPV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intramuscular HPV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intramuscular HPV Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intramuscular HPV Vaccine Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Intramuscular HPV Vaccine Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Intramuscular HPV Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intramuscular HPV Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intramuscular HPV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intramuscular HPV Vaccine Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Intramuscular HPV Vaccine Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Intramuscular HPV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intramuscular HPV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intramuscular HPV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intramuscular HPV Vaccine Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Intramuscular HPV Vaccine Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Intramuscular HPV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intramuscular HPV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intramuscular HPV Vaccine Sales (Units) by Type (2020-2025)
 Table 51. Global Intramuscular HPV Vaccine Sales (Units) by Type (2026-2031)
 Table 52. Global Intramuscular HPV Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Intramuscular HPV Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Intramuscular HPV Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intramuscular HPV Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intramuscular HPV Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Intramuscular HPV Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Intramuscular HPV Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intramuscular HPV Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intramuscular HPV Vaccine Sales (Units) by Application (2020-2025)
 Table 61. Global Intramuscular HPV Vaccine Sales (Units) by Application (2026-2031)
 Table 62. Global Intramuscular HPV Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Intramuscular HPV Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Intramuscular HPV Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intramuscular HPV Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intramuscular HPV Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Intramuscular HPV Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Intramuscular HPV Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intramuscular HPV Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Sharp & Dohme (MSD) Company Information
 Table 71. Merck Sharp & Dohme (MSD) Description and Business Overview
 Table 72. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product
 Table 74. Merck Sharp & Dohme (MSD) Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Intramuscular HPV Vaccine Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Intramuscular HPV Vaccine Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. GSK Company Information
 Table 86. GSK Description and Business Overview
 Table 87. GSK Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. GSK Intramuscular HPV Vaccine Product
 Table 89. GSK Recent Developments/Updates
 Table 90. Serum Institute Company Information
 Table 91. Serum Institute Description and Business Overview
 Table 92. Serum Institute Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Serum Institute Intramuscular HPV Vaccine Product
 Table 94. Serum Institute Recent Developments/Updates
 Table 95. Astellas Pharma Company Information
 Table 96. Astellas Pharma Description and Business Overview
 Table 97. Astellas Pharma Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Astellas Pharma Intramuscular HPV Vaccine Product
 Table 99. Astellas Pharma Recent Developments/Updates
 Table 100. CSL Company Information
 Table 101. CSL Description and Business Overview
 Table 102. CSL Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CSL Intramuscular HPV Vaccine Product
 Table 104. CSL Recent Developments/Updates
 Table 105. Emergent BioSolutions Company Information
 Table 106. Emergent BioSolutions Description and Business Overview
 Table 107. Emergent BioSolutions Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Emergent BioSolutions Intramuscular HPV Vaccine Product
 Table 109. Emergent BioSolutions Recent Developments/Updates
 Table 110. GlaxoSmithKline Company Information
 Table 111. GlaxoSmithKline Description and Business Overview
 Table 112. GlaxoSmithKline Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. GlaxoSmithKline Intramuscular HPV Vaccine Product
 Table 114. GlaxoSmithKline Recent Developments/Updates
 Table 115. Johnson & Johnson Company Information
 Table 116. Johnson & Johnson Description and Business Overview
 Table 117. Johnson & Johnson Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Johnson & Johnson Intramuscular HPV Vaccine Product
 Table 119. Johnson & Johnson Recent Developments/Updates
 Table 120. MedImmune Company Information
 Table 121. MedImmune Description and Business Overview
 Table 122. MedImmune Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. MedImmune Intramuscular HPV Vaccine Product
 Table 124. MedImmune Recent Developments/Updates
 Table 125. Walvax Biotechnology Company Information
 Table 126. Walvax Biotechnology Description and Business Overview
 Table 127. Walvax Biotechnology Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Walvax Biotechnology Intramuscular HPV Vaccine Product
 Table 129. Walvax Biotechnology Recent Developments/Updates
 Table 130. Liaoning Chengda Biotechnology Company Information
 Table 131. Liaoning Chengda Biotechnology Description and Business Overview
 Table 132. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product
 Table 134. Liaoning Chengda Biotechnology Recent Developments/Updates
 Table 135. Hualan Biological Engineering Company Information
 Table 136. Hualan Biological Engineering Description and Business Overview
 Table 137. Hualan Biological Engineering Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Hualan Biological Engineering Intramuscular HPV Vaccine Product
 Table 139. Hualan Biological Engineering Recent Developments/Updates
 Table 140. Sinovac Biotech Company Information
 Table 141. Sinovac Biotech Description and Business Overview
 Table 142. Sinovac Biotech Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Sinovac Biotech Intramuscular HPV Vaccine Product
 Table 144. Sinovac Biotech Recent Developments/Updates
 Table 145. Chongqing Zhifei Biological Products Company Information
 Table 146. Chongqing Zhifei Biological Products Description and Business Overview
 Table 147. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product
 Table 149. Chongqing Zhifei Biological Products Recent Developments/Updates
 Table 150. Chang Chun High and New Technology Industries (Group) Company Information
 Table 151. Chang Chun High and New Technology Industries (Group) Description and Business Overview
 Table 152. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product
 Table 154. Chang Chun High and New Technology Industries (Group) Recent Developments/Updates
 Table 155. Beijing Wantai Biological Pharmacy Enterprise Company Information
 Table 156. Beijing Wantai Biological Pharmacy Enterprise Description and Business Overview
 Table 157. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product
 Table 159. Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
 Table 160. Jiangsu Recbio Technology Company Information
 Table 161. Jiangsu Recbio Technology Description and Business Overview
 Table 162. Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Jiangsu Recbio Technology Intramuscular HPV Vaccine Product
 Table 164. Jiangsu Recbio Technology Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Intramuscular HPV Vaccine Distributors List
 Table 168. Intramuscular HPV Vaccine Customers List
 Table 169. Intramuscular HPV Vaccine Market Trends
 Table 170. Intramuscular HPV Vaccine Market Drivers
 Table 171. Intramuscular HPV Vaccine Market Challenges
 Table 172. Intramuscular HPV Vaccine Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intramuscular HPV Vaccine
 Figure 2. Global Intramuscular HPV Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intramuscular HPV Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Bivalent Product Picture
 Figure 5. Quadrivalent Product Picture
 Figure 6. Nine-valent Product Picture
 Figure 7. Global Intramuscular HPV Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Intramuscular HPV Vaccine Market Share by Application: 2024 & 2031
 Figure 9. Male
 Figure 10. Female
 Figure 11. Global Intramuscular HPV Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Intramuscular HPV Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Intramuscular HPV Vaccine Sales (2020-2031) & (Units)
 Figure 14. Global Intramuscular HPV Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Intramuscular HPV Vaccine Report Years Considered
 Figure 16. Intramuscular HPV Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Intramuscular HPV Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Intramuscular HPV Vaccine Players: Market Share by Revenue in Intramuscular HPV Vaccine in 2024
 Figure 19. Intramuscular HPV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Intramuscular HPV Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Intramuscular HPV Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Intramuscular HPV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Intramuscular HPV Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Intramuscular HPV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Intramuscular HPV Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Intramuscular HPV Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Intramuscular HPV Vaccine Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Intramuscular HPV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Intramuscular HPV Vaccine Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Intramuscular HPV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Intramuscular HPV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Intramuscular HPV Vaccine by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Intramuscular HPV Vaccine by Type (2020-2031)
 Figure 53. Global Intramuscular HPV Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Intramuscular HPV Vaccine by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Intramuscular HPV Vaccine by Application (2020-2031)
 Figure 56. Global Intramuscular HPV Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 57. Intramuscular HPV Vaccine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Intramuscular Vaccine Adjuvants Market Research Report 2025
Global Human Papillomavirus Vaccine Types 16 18 Market Research Report 2024
Cervical Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HPV Vaccine for Men Male HPV Vaccine Market Research Report 2024
Bivalent HPV Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
HPV Quadrivalent Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Papillomavirus 9 Valent Vaccine Market Research Report 2024
HPV Therapeutic Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intramuscular Injector Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
4 valent HPV Vaccine 4vHPV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gardasil HPV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Papillomavirus Infection Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Papillomavirus Bivalent Vaccine Market Research Report 2025
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
HPV Genetically Engineered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pneumococcal Vaccination Market Research Report 2025
Global Human Papillomavirus and Cytomegalovirus Therapeutics Market Research Report 2024
Global Viral Vector Vaccine for Humans Market Research Report 2024
Global Human Papillomavirus Infection Drug Market Research Report 2025
Global HPV Test Reagent kit Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions